Active Biotech AB publ - ESG Rating & Company Profile powered by AI
This page contains a questions and answers table for Active Biotech AB publ. Browse to the end of this webpage for potential risks for Active Biotech AB publ based on industry, geography and size. Detailed Sustainability analysis of Active Biotech AB publ can be reached by logging in.
Active Biotech AB publ in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 217 | Takara Bio Inc | 7.2 | High |
| 217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
| 224 | Active Biotech AB publ | 7.1 | High |
| 224 | Celularity Inc | 7.1 | High |
| 224 | Bilcare Ltd | 7.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Active Biotech AB publ have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Active Biotech AB publ disclose current and historical energy intensity?
Sign up for free to unlockDoes Active Biotech AB publ report the average age of the workforce?
Sign up for free to unlockDoes Active Biotech AB publ reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Active Biotech AB publ disclose its ethnicity pay gap?
Sign up for free to unlockDoes Active Biotech AB publ disclose cybersecurity risks?
Sign up for free to unlockDoes Active Biotech AB publ offer flexible work?
Sign up for free to unlockDoes Active Biotech AB publ have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Active Biotech AB publ disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Active Biotech AB publ conduct supply chain audits?
Sign up for free to unlockDoes Active Biotech AB publ disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Active Biotech AB publ conduct 360 degree staff reviews?
Sign up for free to unlockDoes Active Biotech AB publ disclose the individual responsible for D&I?
Sign up for free to unlockDoes Active Biotech AB publ disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Active Biotech AB publ disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Active Biotech AB publ disclose water use targets?
Sign up for free to unlockDoes Active Biotech AB publ have careers partnerships with academic institutions?
Sign up for free to unlockDid Active Biotech AB publ have a product recall in the last two years?
Sign up for free to unlockDoes Active Biotech AB publ disclose incidents of discrimination?
Sign up for free to unlockDoes Active Biotech AB publ allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Active Biotech AB publ issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Active Biotech AB publ disclose parental leave metrics?
Sign up for free to unlockDoes Active Biotech AB publ disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Active Biotech AB publ disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Active Biotech AB publ disclose the pay ratio of women to men?
Sign up for free to unlockDoes Active Biotech AB publ support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Active Biotech AB publ disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Active Biotech AB publ reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Active Biotech AB publ involved in embryonic stem cell research?
Sign up for free to unlockDoes Active Biotech AB publ disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Active Biotech AB publ disclose its waste policy?
Sign up for free to unlockDoes Active Biotech AB publ report according to TCFD requirements?
Sign up for free to unlockDoes Active Biotech AB publ disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Active Biotech AB publ disclose energy use targets?
Sign up for free to unlockDoes Active Biotech AB publ disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Active Biotech AB publ have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Active Biotech AB publ
These potential risks are based on the size, segment and geographies of the company.
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Biotech AB (publ) was incorporated in 1983 and is headquartered in Lund, Sweden.